PACE (PATHWAYS TO ANTIMICROBIAL CLINICAL EFFICACY)

What this means for you

This application is over — abandoned 18 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

79400685

Mark type

Stylized text

Filed

12 Dec 2023

Abandoned

18 Feb 2025

Goods and services

• Class 035 — Advertising and business services: Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; providing advisory, consultancy and information services in the field of commercialisation of products and services by identifying routes to market for research; compilation of scientific, medical and clinical information; maintenance, namely updating of information in databases in relation to medical and health research.
• Class 036 — Insurance and financial services: Charitable fund raising; charitable collections; organisation of collections; provision of funding for research, education, prevention and treatment of illnesses and human diseases; financial grant services; provision of funding for charities; provision of funding for medical trials; provision of funding for educational and research posts; information and advisory services relating to all the aforesaid; technology transfer services, namely assisting technologies inventors secure appropriate funding to take development forward; technology transfer services, namely managing revenue from partnered or developed intellectual property; all of the aforesaid in relation to medical and health research.
• Class 042 — Scientific and technological services: Scientific, medical and clinical research services, biotechnology research and analysis, biochemical research and analysis, biological research and analysis, clinical trials, data mining in relation to medical and health research, data security services in relation to medical and health research, data encryption services in relation to medical and health research, database design and development in relation to medical and health research, mathematical modelling in relation to medical and health research, bioinformatics, drug discovery services, laboratory research, computer programming and design services in relation to medical and health research; consultancy services relating to all of the foregoing; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; conducting clinical trials for diagnostic tests and for pharmaceutical preparations; providing temporary use of non-downloadable web-based computer software for data integration, exchange, and analysis in relation to medical and health research; providing biomedical and scientific information via a global internet web site related to the field of human health and human diseases; technology transfer services namely product design and development, research and development, product development in relation to medical and health research; antibody humanisation services, namely antibody engineering; biopharmaceutical development; biologic assay development; preclinical research; clinical research; clinical trials management; pharmacovigilance, namely monitoring the effects of medical drugs after they have been licensed for use.

Owner

• LIFEARC, GB

Prosecution history

• 19 Mar 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 05 Mar 2026 — FINAL DISPOSITION NOTICE SENT TO IB
• 05 Mar 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 08 Jan 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 24 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 24 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 05 Mar 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 05 Mar 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 07 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
• 09 Sept 2024 — REFUSAL PROCESSED BY IB
• 19 Aug 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 17 Aug 2024 — REFUSAL PROCESSED BY MPU
• 08 Aug 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 07 Aug 2024 — NON-FINAL ACTION WRITTEN
• 30 Jul 2024 — ASSIGNED TO EXAMINER